Introduction
The Brain Tumor Therapeutics Market is estimated at USD 3.19 billion in 2025 and is expected to reach USD 4.67 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.89%. This projected expansion comes amid breakthroughs in precision medicine, the emergence of fast-tracked therapies such as Boron Neutron Capture Therapy (BNCT) and increasing integration of AI-driven drug repurposing tools tailored to glioma and other aggressive tumors.
Report Overview: https://www.mordorintelligence.com/industry-reports/brain-tumor-therapeutics-market?utm_source=emailwire
Key Trends
- Precision medicine reshaping therapy development
Innovative treatments now focus on targeting genetic drivers and molecular markers of brain tumors, moving beyond traditional approaches.
- BNCT entering clinical use
This novel therapeutic option is gaining traction for its potential to precisely target high-grade tumors.
- AI-powered repurposing expanding options
Artificial intelligence is streamlining identification of effective drugs, shortening development timelines and boosting treatment accessibility.
- Shift toward oral targeted therapies
While intravenous administration remains common due to pharmacokinetic control, improved blood–brain barrier penetration is driving the rise of oral agents.
- Glioblastoma remains the largest segment
Therapies targeting glioblastoma continue to dominate market share, reflecting clinical burden and ongoing R&D focus.
- Asia-Pacific emerges as the leading growth region
The convergence of expanding healthcare infrastructure and growing R&D investments is fueling rapid market growth in this region.
- North America retains lead position
Strong regulatory frameworks, reimbursement pathways, and established clinical networks help North America remain top in revenue share.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/brain-tumor-therapeutics-market?utm_source=emailwire
Market Segmentation
By Type of Brain Cancer
- Glioblastoma
- Meningioma
- Pituitary Tumors
- Ependymoma
- Medulloblastoma
- Other Rare Tumors
By Therapy
- Chemotherapy
- Immunotherapy
- Gene & Cell Therapy
- Targeted Small-Molecule Therapy
- Tumor-Treating Fields (TTF) & Electro-therapy
- Radiotherapy Adjuncts
By Route of Administration
- Oral
- Intravenous
- Intrathecal / Intraventricular
- Convection-Enhanced Delivery
By Region:
- North America
- Asia-Pacific
- Europe
- South America
- Middle East Africa
Explore Our Full Library of Healthcare Research Industry Reports: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire
Key Players
Mordor Intelligence identifies major contributors active in the global brain tumor therapeutics space:
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Eisai Inc.
- Novartis AG
- Merck & Co. Inc.
These organizations are engaged in advancing targeted therapies, novel cytotoxic modalities, and device-supported options that are transforming the brain tumor treatment landscape.
To know more about the major players in the market, visit: https://www.mordorintelligence.com/industry-reports/brain-tumor-therapeutics-market/companies?utm_source=emailwire
Conclusion
The Brain Tumor Therapeutics Market is on track to grow from USD 3.19 billion in 2025 to USD 4.67 billion by 2030, exhibiting a CAGR of 7.89%. Key drivers include precision oncology breakthroughs, the emergence of BNCT, and AI-informed repurposing strategies—especially pertinent to glioblastoma, which continues to command the largest treatment share.
The dominance of North America underscores its robust clinical R&D environment, while Asia-Pacific is emerging as a high-growth region with increasing access and investment. Intravenous administration remains standard, but oral incorporation is rising, enabling better patient convenience. As smart therapeutics, novel laser-guided dose options, and combo regimens gain momentum, established players like AstraZeneca and Bristol-Myers Squibb—alongside innovative developers—are positioned for leadership.
For complete market analysis, visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/brain-tumor-therapeutics-market?utm_source=emailwire
Industry Related Reports
Adult Malignant Glioma Therapeutics Market: The Adult Malignant Glioma Therapeutics Market Report is Segmented by Disease Type (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, and More), Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Device-Based Therapy, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).
Get more insights: https://www.mordorintelligence.com/industry-reports/adult-malignant-glioma-therapeutics-market?utm_source=emailwire
Glioblastoma Multiforme Treatment Market : The Glioblastoma Multiforme Treatment Market Report is Segmented by Treatment Modality (Chemotherapy, Radiation Therapy, and More), Patient Type (Newly Diagnosed GBM, Recurrent GBM), End User (Hospitals and Clinics, and More), Age Group (Adults, Pediatric, Geriatric), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Get more insights: https://www.mordorintelligence.com/industry-reports/glioblastoma-multiforme-treatment-market?utm_source=emailwire
Acoustic Neuroma Market: The Report Covers Global Acoustic Neuroma Treatment Market Analysis and is Segmented by Diagnosis (Audiometry, Electronystagmography, Magnetic Resonance Imaging, Others), Treatment Type (Drugs and Radiation Therapy), End Users (Hospitals, Clinics, Other End Users), Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Get more insights: https://www.mordorintelligence.com/industry-reports/acoustic-neuroma-market?utm_source=emailwire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
